株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

ヘリコバクターピロリ診断の世界市場:2020年~2024年

Global Helicobacter Pylori Diagnostics Market 2020-2024

発行 TechNavio (Infiniti Research Ltd.) 商品コード 531736
出版日 ページ情報 英文 120 Pages
即納可能
価格
本日の銀行送金レート: 1USD=109.72円で換算しております。
ヘリコバクターピロリ診断の世界市場:2020年~2024年 Global Helicobacter Pylori Diagnostics Market 2020-2024
出版日: 2020年04月30日 ページ情報: 英文 120 Pages
概要

世界のヘリコバクターピロリ診断市場は、2020年から2024年の予測期間中に8%のCAGRで成長し、2億959万米ドルの規模に達する見込みです。 市場は、オーダーメード抗生物質療法と合わせた診断の費用対効果の改善、およびピロリ菌の抗生物質に対する耐性が、主な成長要因となっています。特に、オーダーメード抗生物質療法と組み合わせた診断の費用対効果の改善によって、市場成長が更に促進される見通しです。

当レポートでは、世界のヘリコバクターピロリ診断市場について調査分析し、市場規模および成長率、市場動向、市場促進要因、課題、市場機会について検証するほか、主要ベンダーなどについて、体系的な情報を提供しています。

目次

エグゼクティブサマリー

市場情勢

市場規模

  • 市場の定義
  • 市場セグメント分析
  • 2019年の市場規模
  • 市場の見通し:2019年から2024年の予測

ファイブフォース分析

技術別市場セグメンテーション

  • 市場セグメンテーション
  • 技術別比較:市場規模・予測(2019年~2024年)
  • イムノアッセイ
  • 分子診断
  • POC
  • 技術別の市場機会

顧客情勢

地域別情勢

  • 地域別セグメンテーション
  • 地域別比較:市場規模・予測(2019年~2024年)
  • 北米
  • 欧州
  • アジア太平洋地域
  • その他の地域
  • 主要国
  • 地域別の市場機会

成長要因、課題、および動向

  • 市場成長要因
  • 数量ベースの成長要因-需要主導型成長
  • 数量ベースの成長要因-外部要因
  • 市場の課題
  • 市場動向

ベンダー情勢

  • ベンダー情勢
  • 情勢の革新

ベンダー分析

  • 対象ベンダー
  • ベンダーの市場ポジショニング
  • Abbott Laboratories
  • bioMerieux SA
  • Bio-Rad Laboratories Inc.
  • Cardinal Health Inc.
  • F. Hoffmann-La Roche Ltd.
  • Omega Diagnostics Group Plc
  • QIAGEN N.V.
  • Quest Diagnostics Inc.
  • Thermo Fisher Scientific Inc.

付録

目次
Product Code: IRTNTR41646

Technavio has been monitoring the helicobacter pylori diagnostics market and it is poised to grow by $ 209.59 mn during 2020-2024 progressing at a CAGR of 8% during the forecast period. Our reports on helicobacter pylori diagnostics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the growing cost-effectiveness of diagnosis in conjunction with personalized antibiotic therapy and resistance of H. pylori to antibiotics. In addition, growing cost-effectiveness of diagnosis in conjunction with personalized antibiotic therapy is anticipated to boost the growth of the market as well.

The helicobacter pylori diagnostics market analysis includes technology segment and geographic landscapes

Technavio's ‘ helicobacter pylori diagnostics market ’ is segmented as below:

By Technology:

  • Immunoassays
  • Molecular diagnostics
  • POC

By Geographic Landscape:

  • North America
  • Europe
  • APAC

This study identifies the rising prevalence of disease as one of the prime reasons driving the helicobacter pylori diagnostics market growth during the next few years.

"Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our helicobacter pylori diagnostics market covers the following areas:

  • Helicobacter pylori diagnostics market sizing
  • Helicobacter pylori diagnostics market forecast
  • Helicobacter pylori diagnostics market industry analysis"

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading helicobacter pylori diagnostics market vendors that include Abbott Laboratories, Becton, Dickinson and Co., bioMA©rieux SA, Bio-Rad Laboratories Inc., Cardinal Health Inc., F. Hoffmann-La Roche Ltd., Omega Diagnostics Group Plc, QIAGEN N.V., Quest Diagnostics Inc., and Thermo Fisher Scientific Inc.. Also, the helicobacter pylori diagnostics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.

Table of Contents

Executive Summary

  • Market Overview

Market Landscape

  • Market ecosystem
  • Value chain analysis

Market Sizing

  • Market definition
  • Market segment analysis
  • Market size 2019
  • Market outlook: Forecast for 2019 - 2024

Five Forces Analysis

  • Five Forces Summary
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

Market Segmentation by Technology

  • Market segments
  • Comparison by Technology
  • Immunoassays - Market size and forecast 2019-2024
  • Molecular diagnostics - Market size and forecast 2019-2024
  • POC - Market size and forecast 2019-2024
  • Market opportunity by Technology

Customer landscape

Geographic Landscape

  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2019-2024
  • Europe - Market size and forecast 2019-2024
  • APAC - Market size and forecast 2019-2024
  • ROW - Market size and forecast 2019-2024
  • Key leading countries
  • Market opportunity by geography
  • Volume driver - Demand led growth
  • Volume driver - External factors
  • Market challenges
  • Market trends

Vendor Landscape

  • Vendor landscape
  • Landscape disruption

Vendor Analysis

  • Vendors covered
  • Market positioning of vendors
  • Abbott Laboratories
  • bioMerieux SA
  • Bio-Rad Laboratories Inc.
  • Cardinal Health Inc.
  • F. Hoffmann-La Roche Ltd.
  • Omega Diagnostics Group Plc
  • QIAGEN N.V.
  • Quest Diagnostics Inc.
  • Thermo Fisher Scientific Inc.

Appendix

  • Scope of the report
  • Currency conversion rates for US$
  • Research methodology
  • List of abbreviations

Exhibit

  • 1.Key Finding 1
  • 2.Key Finding 2
  • 3.Key Finding 3
  • 4.Key Finding 5
  • 5.Key Finding 6
  • 6.Key Finding 7
  • 7.Key Finding 8
  • 8.Market in focus
  • 9.Parent market
  • 10.Market characteristics
  • 11.Offerings of vendors included in the market definition
  • 12.Market segments
  • 13.Global - Market size and forecast 2019 - 2024 ($ million)
  • 14.Global market: Year-over-year growth 2019 - 2024 (%)
  • 15.Five forces analysis 2019 & 2024
  • 16.Bargaining power of buyers
  • 17.Bargaining power of suppliers
  • 18.Threat of new entrants
  • 19.Threat of substitutes
  • 20.Threat of rivalry
  • 21.Market condition - Five forces 2019
  • 22.Technology placement - Market share 2019-2024 (%)
  • 23.Comparison by Technology
  • 24.Immunoassays - Market size and forecast 2019-2024 ($ million)
  • 25.Immunoassays - Year-over-year growth 2019-2024 (%)
  • 26.Molecular diagnostics - Market size and forecast 2019-2024 ($ million)
  • 27.Molecular diagnostics - Year-over-year growth 2019-2024 (%)
  • 28.POC - Market size and forecast 2019-2024 ($ million)
  • 29.POC - Year-over-year growth 2019-2024 (%)
  • 30.Market opportunity by Technology
  • 31.Customer landscape
  • 32.Market share by geography 2019-2024 (%)
  • 33.Geographic comparison
  • 34.North America - Market size and forecast 2019-2024 ($ million)
  • 35.North America - Year-over-year growth 2019-2024 (%)
  • 36.Europe - Market size and forecast 2019-2024 ($ million)
  • 37.Europe - Year-over-year growth 2019-2024 (%)
  • 38.APAC - Market size and forecast 2019-2024 ($ million)
  • 39.APAC - Year-over-year growth 2019-2024 (%)
  • 40.ROW - Market size and forecast 2019-2024 ($ million)
  • 41.ROW - Year-over-year growth 2019-2024 (%)
  • 42.Key leading countries
  • 43.Market opportunity by geography ($ million)
  • 44.Impact of drivers and challenges
  • 45.Vendor landscape
  • 46.Landscape disruption
  • 47.Industry risks
  • 48.Vendors covered
  • 49.Market positioning of vendors
  • 50.Abbott Laboratories - Overview
  • 51.Abbott Laboratories - Business segments
  • 52.Abbott Laboratories - Key offerings
  • 53.Abbott Laboratories - Key customers
  • 54.Abbott Laboratories - Segment focus
  • 55.Becton, Dickinson and Co. - Overview
  • 56.Becton, Dickinson and Co. - Business segments
  • 57.Becton, Dickinson and Co. - Key offerings
  • 58.Becton, Dickinson and Co. - Key customers
  • 59.Becton, Dickinson and Co. - Segment focus
  • 60.bioMerieux SA - Overview
  • 61.bioMerieux SA - Business segments
  • 62.bioMerieux SA - Key offerings
  • 63.bioMerieux SA - Key customers
  • 64.bioMerieux SA - Segment focus
  • 65.Bio-Rad Laboratories Inc. - Overview
  • 66.Bio-Rad Laboratories Inc. - Business segments
  • 67.Bio-Rad Laboratories Inc. - Key offerings
  • 68.Bio-Rad Laboratories Inc. - Key customers
  • 69.Bio-Rad Laboratories Inc. - Segment focus
  • 70.Cardinal Health Inc. - Overview
  • 71.Cardinal Health Inc. - Business segments
  • 72.Cardinal Health Inc. - Key offerings
  • 73.Cardinal Health Inc. - Key customers
  • 74.Cardinal Health Inc. - Segment focus
  • 75.F. Hoffmann-La Roche Ltd. - Overview
  • 76.F. Hoffmann-La Roche Ltd. - Business segments
  • 77.F. Hoffmann-La Roche Ltd. - Key offerings
  • 78.F. Hoffmann-La Roche Ltd. - Key customers
  • 79.F. Hoffmann-La Roche Ltd. - Segment focus
  • 80.Omega Diagnostics Group Plc - Overview
  • 81.Omega Diagnostics Group Plc - Business segments
  • 82.Omega Diagnostics Group Plc - Key offerings
  • 83.Omega Diagnostics Group Plc - Key customers
  • 84.Omega Diagnostics Group Plc - Segment focus
  • 85.QIAGEN N.V. - Overview
  • 86.QIAGEN N.V. - Business segments
  • 87.QIAGEN N.V. - Key offerings
  • 88.QIAGEN N.V. - Key customers
  • 89.QIAGEN N.V. - Segment focus
  • 90.Quest Diagnostics Inc. - Overview
  • 91.Quest Diagnostics Inc. - Business segments
  • 92.Quest Diagnostics Inc. - Key offerings
  • 93.Quest Diagnostics Inc. - Key customers
  • 94.Quest Diagnostics Inc. - Segment focus
  • 95.Thermo Fisher Scientific Inc. - Overview
  • 96.Thermo Fisher Scientific Inc. - Business segments
  • 97.Thermo Fisher Scientific Inc. - Key offerings
  • 98.Thermo Fisher Scientific Inc. - Key customers
  • 99.Thermo Fisher Scientific Inc. - Segment focus
  • 100.Currency conversion rates for US$
  • 101.Research Methodology
  • 102.Validation techniques employed for market sizing
  • 103.Information sources
  • 104.List of abbreviations